Reply to: “correspondence about “Efficacy and safety of basiliximab”

• Mohamed Hashim,
• Ayman Alsebaey,
• Amr Ragab,
• Hossam Eldeen Soliman,
• Imam Waked

Affiliations

Mohamed Hashim

Department of Hepatology, National Liver Institute, Menoufiya University, Shebin Elkom, Egypt; Corresponding author.

Ayman Alsebaey

Department of Hepatology, National Liver Institute, Menoufiya University, Shebin Elkom, Egypt

Amr Ragab

Department of Hepatology, National Liver Institute, Menoufiya University, Shebin Elkom, Egypt

Hossam Eldeen Soliman

Department of Hepatobiliary and Pancreatic Surgery, National Liver Institute, Menoufiya University, Shebin Elkom, Egypt

Imam Waked

Department of Hepatology, National Liver Institute, Menoufiya University, Shebin Elkom, Egypt